Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Schwind
Increased Anti-Leukemic Activity of Decitabine via AR-42-induced Upregulation of miR-29b: A Novel Epigenetic-Targeting Approach in Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
UVA (UVA-1) Therapy for the Treatment of Acute GVHD of the Skin
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Awareness of Emerging Novel Epigenetic Targeting Therapy in Acute Myeloid Leukemia
Cancer therapy & Oncology International Journal
Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
Cells
An Auristatin Nanoconjugate Targeting CXCR4+ Leukemic Cells Blocks Acute Myeloid Leukemia Dissemination
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Upregulation of Mir-99a Is Associated With Poor Prognosis of Acute Myeloid Leukemia and Promotes Myeloid Leukemia Cell Expansion
Blood
Biochemistry
Immunology
Cell Biology
Hematology
In Vitro and in Vivo Anti-Leukemic Activity of the Peptidase-Potentiated Alkylator Melflufen in Acute Myeloid Leukemia
Oncotarget
Oncology
Altered Expression Pattern of miR-29a, miR-29b and the Target Genes in Myeloid Leukemia
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
The Epigenetic Landscape of Acute Myeloid Leukemia
Advances in Hematology
Hematology
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
PLoS ONE
Multidisciplinary
Novel Agents in Acute Myeloid Leukemia
International Journal of Hematology
Hematology
